Pusan National University

Biliary tract
#Biliary tract cancer #Chemotherapy #Oncology #Pusan National University #Yonsei University

Study finds new treatment option for biliary tract cancer

Researchers have found that that FOLFIRINOX, a chemotherapy used for pancreatic cancer, may improve survival in advanced biliary tract cancer (BTC) patients.  A new collaborative study from Pusan National University and Yonsei University suggests that the FOLFIRINOX regimen showed numerically improved survival outcomes compared to current standards… Read More

#Cancer Research #News

Janus kinase 1 protein
#Adverse event #Atopic dermatitis #Dermatology #JAK inhibitor #Korea #Pusan National University

Do JAK inhibitors increase the risk of serious adverse events?

South Korean researchers have found that the use of Janus kinase (JAK) inhibitors as a treatment for atopic dermatitis (AD) is not associated with a greater risk of serious adverse events. While several biologic treatment approaches have been proposed in the recent years for the treatment… Read More

#News